Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Alligator Bioscience AB ( (SE:ATORX) ) just unveiled an update.
Alligator Bioscience AB has announced a rights issue to raise approximately SEK 123 million, with the potential for an additional SEK 61 million through warrants. The funds will be used to repay loans and support the ongoing process to secure a partnership for mitazalimab, as well as for general corporate purposes. The rights issue is partially covered by subscription undertakings and guarantee commitments, ensuring a significant portion of the funds is secured.
More about Alligator Bioscience AB
Alligator Bioscience AB operates in the biotechnology industry, focusing on the development of antibody-based therapies for cancer treatment. The company is engaged in creating innovative immunotherapies aimed at improving the lives of cancer patients.
Average Trading Volume: 1,189,816
Technical Sentiment Signal: Sell
Current Market Cap: SEK29.57M
Learn more about ATORX stock on TipRanks’ Stock Analysis page.